C. J. Vecht

818 total citations
17 papers, 613 citations indexed

About

C. J. Vecht is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. J. Vecht has authored 17 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. J. Vecht's work include Cancer Treatment and Pharmacology (4 papers), Glioma Diagnosis and Treatment (3 papers) and Multiple Myeloma Research and Treatments (3 papers). C. J. Vecht is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Glioma Diagnosis and Treatment (3 papers) and Multiple Myeloma Research and Treatments (3 papers). C. J. Vecht collaborates with scholars based in Netherlands, Austria and France. C. J. Vecht's co-authors include Martin J. van den Bent, Johanna M. M. Gijtenbeek, Jaap Verweij, P.H.E. Hilkens, G. Stoter, B. A. Kazzaz, L. Pronk, A. Hovestadt, H Verbiest and Wim L.J. van Putten and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. J. Vecht

14 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. J. Vecht Netherlands 8 190 174 152 109 90 17 613
Susan Booher United States 12 170 0.9× 54 0.3× 27 0.2× 132 1.2× 129 1.4× 16 847
P. O’Connor Canada 10 242 1.3× 87 0.5× 21 0.1× 221 2.0× 152 1.7× 16 1.0k
Barbara Frigeni Italy 16 736 3.9× 116 0.7× 67 0.4× 196 1.8× 30 0.3× 25 1.2k
Katsuhiko Oguro Japan 10 252 1.3× 90 0.5× 83 0.5× 46 0.4× 193 2.1× 19 653
Ivo W. Tremont‐Lukats United States 15 204 1.1× 147 0.8× 191 1.3× 227 2.1× 9 0.1× 42 1.3k
Britt Lauenborg Denmark 10 289 1.5× 80 0.5× 76 0.5× 19 0.2× 14 0.2× 11 1.1k
Daniela Rizzo Italy 17 102 0.5× 17 0.1× 138 0.9× 106 1.0× 22 0.2× 37 705
Takahisa Noto Japan 17 66 0.3× 56 0.3× 27 0.2× 20 0.2× 40 0.4× 47 636
Ann‐Shung Lieu Taiwan 17 55 0.3× 86 0.5× 62 0.4× 201 1.8× 20 0.2× 55 910
Jean‐Yves Devaux France 13 77 0.4× 25 0.1× 29 0.2× 91 0.8× 44 0.5× 36 1.0k

Countries citing papers authored by C. J. Vecht

Since Specialization
Citations

This map shows the geographic impact of C. J. Vecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. J. Vecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. J. Vecht more than expected).

Fields of papers citing papers by C. J. Vecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. J. Vecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. J. Vecht. The network helps show where C. J. Vecht may publish in the future.

Co-authorship network of co-authors of C. J. Vecht

This figure shows the co-authorship network connecting the top 25 collaborators of C. J. Vecht. A scholar is included among the top collaborators of C. J. Vecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. J. Vecht. C. J. Vecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bent, Martin J. van den, Alba A. Brandes, Martin Taphoorn, et al.. (2012). LONG TERM FOLLOW-UP RESULTS OF EORTC 26951: A RANDOMIZED PHASE III STUDY ON ADJUVANT PCV CHEMOTHERAPY IN ANAPLASTIC OLIGODENDROGLIAL TUMORS - A REPORT OF THE EORTC BRAIN TUMOR GROUP. Neuro-Oncology. 14. 12–12.
2.
Groot, M. de, et al.. (2010). High Sv2A Expression in Tumor and Peritumoral Tissue in Glioma Patients with Epilepsy Is Associated with High Efficacy of Levetiracetam. Neuro-Oncology. 12. 75–75. 4 indexed citations
3.
Groot, M. de, et al.. (2010). Efficacy and Tolerability of Levetiracetam Monotherapy in Patients with Primary Brain Tumors and Epilepsy. Neuro-Oncology. 12. 43–44. 1 indexed citations
4.
Oosterkamp, Hendrika M., et al.. (2010). Use of perfusion MR imaging for differentiation between tumor progression and pseudo-progression in recurrent glioblastoma multiforme.. Journal of Clinical Oncology. 28(15_suppl). 2026–2026. 3 indexed citations
5.
Gijtenbeek, Johanna M. M., Martin J. van den Bent, & C. J. Vecht. (1999). Cyclosporine neurotoxicity: a review. Journal of Neurology. 246(5). 339–346. 326 indexed citations
6.
Pronk, L., et al.. (1997). Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin. British Journal of Cancer. 75(3). 417–422. 57 indexed citations
7.
Hilkens, P.H.E., Jaap Verweij, C. J. Vecht, G. Stoter, & Martin J. van den Bent. (1997). Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere). Annals of Oncology. 8(2). 187–190. 77 indexed citations
8.
Vecht, C. J., et al.. (1996). Towards better pain treatment in cancer. Anti-Cancer Drugs. 7(1). 3–26. 2 indexed citations
9.
Markusse, H. M., P.H.E. Hilkens, Martin J. van den Bent, & C. J. Vecht. (1995). Normal pressure hydrocephalus associated with rheumatoid arthritis responding to prednisone.. PubMed. 22(2). 342–3. 6 indexed citations
10.
Planting, A.S.T., PHM de Mulder, Alexander de Graeff, C. J. Vecht, & Jaco J. Verweij. (1993). Phase II study of a short course of weekly cisplatin (C) in locally advanced squamous cell carcinoma (SCC) of the head and neck. European Journal of Cancer. 29. S141–S141. 1 indexed citations
11.
Moll, J., et al.. (1993). MATTERS ARISING: Moll et al reply:. Journal of Neurology Neurosurgery & Psychiatry. 56(12). 1338–1338. 1 indexed citations
12.
Gispen, W.H., et al.. (1992). ACTH/MSH like peptides in the treatment of cisplatin neuropathy. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 179–183. 24 indexed citations
13.
Hovestadt, A., M.E.L. van der Burg, H Verbiest, Wim L.J. van Putten, & C. J. Vecht. (1992). The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo. Journal of Neurology. 239(3). 143–146. 40 indexed citations
14.
Markusse, H. M., et al.. (1991). Polyneuropathy as initial manifestation of necrotizing vasculitis and gangrene in systemic lupus erythematosus.. PubMed. 38(5-6). 204–8. 2 indexed citations
15.
Henzen‐Logmans, S.C., et al.. (1990). Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous system.. Journal of Neurology Neurosurgery & Psychiatry. 53(11). 940–943. 24 indexed citations
16.
Kazzaz, B. A., et al.. (1987). Segmental rigidity and spinal myoclonus as a paraneoplastic syndrome.. Journal of Neurology Neurosurgery & Psychiatry. 50(5). 628–631. 35 indexed citations
17.
Maat, B., et al.. (1979). Transplantability and metastatic potential of chemically induced rat brain tumours.. PubMed. 31(8). 228–30. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026